한글목차

자궁경부이형성 세계 시장은 2025년에는 8억 2,220만 달러로 추정되며, 2032년에는 13억 6,400만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 성장률(CAGR) 7.5%로 성장할 것으로 예상됩니다.

그림. 자궁경부이형성 시장 점유율(%), 지역별, 2025년

자궁경부이형성은 자궁의 입구인 자궁경부의 내막을 구성하는 세포의 전암성 변화입니다. 이러한 변화는 골반 검사 중 자궁경부에서 채취한 세포 샘플을 현미경으로 분석하여 발견할 수 있습니다. 편평상피내 병변은 자궁경부에서 채취한 세포 도말 샘플에서 관찰되는 자궁경부이형성을 일컫는 병리학 용어입니다. 자궁경부이형성은 인유두종바이러스(HPV)의 감염에 의해 발생하며, HPV는 성접촉을 통해 감염되는 매우 흔한 감염 질환입니다. 신규 HPV 감염의 대부분은 젊은(15-25세) 여성에게 발생합니다. 대부분의 HPV 감염은 증상이 나타나지 않고 자연 치유됩니다.

시장 역학

주요 시장 진입 기업들의 유기적 전략의 증가는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2021년 3월 1일, 감염, 암, HPV 관련 질환의 치료 및 예방을 위해 정밀하게 설계된 데옥시리보핵산(DNA) 의약품의 출시에 주력하는 생명공학 기업 이노비오(Inovio)는 REVEAL 1 시험의 모든 평가 가능한 피험자에서 주요 평가변수와 부수적 평가변수를 달성했다고 발표했습니다. 했다고 발표했습니다. 이 시험은 HPV-16/18 관련 자궁경부 고악성 편평상피내병변(HSIL)에 대한 VGX-3100의 안전성, 내약성, 유효성을 이노비오의 셀렉트라 5PSP 장비를 통해 평가하기 위해 진행 중인 2건의 중요한 무작위 이중맹검 다기관 위약대조 3상 시험 중 하나입니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
• 정부 이니셔티브 강화
• 자궁경부이형성 유병률이 세계적으로 증가
  • 성장 억제요인
• 개발도상국의 의식의 결여
  • 기회
• 정부의 자금 지원 증가
• 규제 시나리오
• 제품 발매/승인
• PEST 분석
• Porters 분석
• 합병, 인수, 제휴

제4장 자궁경부 이형성시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 자궁경부 이형성시장, 진단 유형별, 2020-2032년

• 소개
• 진단 검사
• HPV 검사
• 팹 스미어 검사
• 생검 검사
• 진단 장비
• 질경

제6장 자궁경부 이형성시장, 최종사용자별, 2020-2032년

• 소개
• 병원
• 진단 센터
• 외래 수술 센터

제7장 자궁경부 이형성시장, 지역별, 2020-2032년

• 소개
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제8장 경쟁 구도

• 기업 개요
  • Roche
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical

제9장 섹션

• 참고문헌
• 조사 방법
• 출판사 소개

영문목차

Global Cervical Dysplasia Market is estimated to be valued at USD 822.2 Mn in 2025 and is expected to reach USD 1,364. Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Figure. Cervical Dysplasia Market Share (%), By Region 2025

Cervical dysplasia is precancerous changes of the cells that make up the lining of the cervix, the opening to the womb (uterus). These changes are detected by microscopic analysis of cell samples which are taken from the cervix during a pelvic exam. Squamous intraepithelial lesion is the pathology term that is used to refer to cervical dysplasia which is observed in smears of cells taken from the cervix. Cervical dysplasia is caused by infection with the human papillomavirus (HPV). HPV is a very common infection that is transmitted through sexual contact. Most new HPV infections occur in young (ages 15-25) women. Most HPV infections do not produce any symptoms and resolve spontaneously.

Market Dynamics:

Increasing organic strategies by the key market players is expected to drive the market growth over the forecast period. For instance, on March 1, 2021, INOVIO, a biotechnology company focused on bringing to market precisely designed deoxyribonucleic acid (DNA)medicines to treat and protect people from infectious diseases, cancer and HPV-associated diseases, announced that it met primary and secondary endpoints among all evaluable subjects for the REVEAL 1 trial. This trial is one of two ongoing pivotal, randomized, double-blind, multi-center, placebo-controlled, Phase 3 trials evaluating the safety, tolerability, and efficacy of VGX-3100 to treat HPV-16/18-associated cervical high-grade squamous intraepithelial lesions (HSIL) using the company's proprietary CELLECTRA 5PSP device.

Cervical Dysplasia Market Detailed Segmentation:

• By Diagnosis Type
  • Diagnosis Test
  • HPV Test
  • Pap Smear Test
  • Biopsy Test
  • Diagnostic Device
  • Colposcope
• By End User
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Roche
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Diagnosis Type
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing government initiatives
• Growing prevalence of cervical dysplasia globally
  • Restraints
• Lack of awareness in developing nations
  • Opportunities
• Increasing government funding
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions and Collaborations

4. Cervical Dysplasia Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Cervical Dysplasia Market, By Diagnosis Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnosis Test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• HPV Test
• Pap Smear Test
• Biopsy Test
• Diagnostic Device
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Colposcope

6. Cervical Dysplasia Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Cervical Dysplasia Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2025and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Company Profile
  • Roche
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Qiagen
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Abbott Laboratories
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical
  • Analyst Views

9. Section

• References
• Research Methodology
• About us